Keyphrases
Acute Coronary Syndrome
21%
Adverse Cardiac Events
36%
Antihypertensive Medication
30%
Balloon
10%
Bifurcation Lesion
24%
Bleeding
12%
Blood Pressure
19%
Catheter-based Renal Denervation
19%
Clinical Application
13%
Clinical Outcomes
15%
Confidence Interval
23%
Coronary Bifurcation Lesions
27%
Coronary Lesions
17%
Coronary Revascularization
12%
Delayed Revascularization
27%
Diastolic Blood Pressure
14%
Diastolic Function
24%
E Wave
21%
Elective Percutaneous Coronary Intervention
18%
Fractional Flow Reserve
92%
High Risk
16%
In-stent Restenosis
11%
Instantaneous Wave-free Ratio
54%
Intravascular Ultrasound
58%
Jailed Balloon Technique
18%
Left Ventricular End-diastolic Pressure
32%
Left Ventricular Function
30%
Long-term Clinical Outcome
20%
Model-based Image Processing
18%
Myocardial Infarction
21%
Percutaneous Coronary Intervention
62%
Phase Plane
18%
Phase Plane Analysis
11%
Physiologic
11%
Pressure Contour
11%
Randomized Clinical Trial
10%
Renal Artery
11%
Renal Denervation
34%
Resistant Hypertension
18%
Restenosis
15%
Revascularization
43%
Same-day Discharge
18%
Sham Control
30%
Side Branch
13%
Symplicity
18%
Systolic Blood Pressure
38%
Target Lesion Revascularization
17%
Transmitral Flow
21%
Ultrasound-guided Treatments
10%
Uncontrolled Hypertension
13%
Medicine and Dentistry
Acute Coronary Syndrome
22%
Acute Kidney Injury
9%
Antihypertensive Agent
28%
Bleeding
14%
Blood Pressure
23%
Cannulation
9%
Cardiac Catheterization
13%
Cardiogenic Shock
11%
Cardiovascular System
17%
CATH
9%
Congestive Heart Failure
11%
Coronary Artery
10%
Coronary Artery Disease
18%
Coronary Artery Obstruction
10%
Coronary Bifurcation Lesion
27%
Denervation
9%
Diastolic Blood Pressure
15%
Diastolic Function
29%
Drug Therapy
30%
Exercise
9%
Fractional Flow Reserve
91%
Hazard Ratio
13%
Health Care Cost
22%
Heart Left Ventricle Enddiastolic Pressure
12%
Heart Left Ventricle Pressure
20%
Heart Muscle Revascularization
12%
Hemodynamic
23%
In-Stent Restenosis
12%
Intravascular Ultrasound
58%
Kidney Denervation
36%
Laser Angioplasty
9%
Left Coronary Artery
9%
Major Adverse Cardiac Event
24%
Maturity Onset Diabetes of the Young
9%
Minimal Effective Dose
28%
Myocardial Infarction
29%
Pediatrics
9%
Percutaneous Coronary Intervention
100%
Randomized Clinical Trial
10%
Renal Artery
19%
Restenosis
15%
Revascularization
78%
Rheumatoid Arthritis
9%
Sex Difference
9%
Smooth Muscle
9%
Stable Angina Pectoris
9%
Stenting
27%
Systolic Blood Pressure
29%
Target Lesion Revascularization
18%
Thorax Injury
9%